Colgate-Palmolive Schedules Q1 2026 Earnings Call
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 days ago
0mins
Should l Buy CL?
Source: Newsfilter
- Earnings Call Announcement: Colgate-Palmolive will host its Q1 2026 earnings conference call on May 1, 2026, at 8:30 a.m. ET, featuring insights from Chairman and CEO Noel Wallace and other executives, providing a detailed analysis of the company's financial performance.
- Investor Access: Investors can access the earnings press release, prepared materials, and the live audio webcast on Colgate's website, ensuring that all stakeholders stay informed about the latest financial updates and corporate developments.
- Recorded Playback Availability: For those unable to attend the live session, Colgate will offer a recorded version of the conference call, enhancing information accessibility and transparency for investors seeking to catch up on key discussions.
- Company Mission and Vision: Colgate is committed to promoting sustainability and community well-being through its innovative products in oral care, personal care, home care, and pet nutrition, highlighting its leadership position in the global market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CL
Wall Street analysts forecast CL stock price to rise
15 Analyst Rating
10 Buy
4 Hold
1 Sell
Moderate Buy
Current: 83.530
Low
77.00
Averages
87.79
High
95.00
Current: 83.530
Low
77.00
Averages
87.79
High
95.00
About CL
Colgate-Palmolive Company is a growth company. It is focused on Oral Care, Personal Care, Home Care and Pet Nutrition, it sells its products under brands, such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. Its Oral, Personal and Home Care product segment is managed geographically in five segments, such as North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and e-commerce retailers, wholesalers, distributors, dentists and skin health professionals. Its Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and e-commerce retailers.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Market Volatility Analysis: The S&P 500 index experienced a sharp decline in March and April due to the onset of the Iran war but has since recovered by 4.1% as of April 17, indicating market resilience, although higher energy prices may dampen consumer spending and overall economic performance.
- Colgate-Palmolive's Strong Performance: Colgate-Palmolive has achieved a 9.3% return this year, with projected sales growth of 1.4% for 2025, and generated $3.6 billion in free cash flow, ensuring the stability of its 2.55% dividend yield, showcasing its resilience amid economic uncertainty.
- American States Water's Stable Growth: American States Water's adjusted diluted earnings per share grew by 10.9% in 2025 to $3.37, with a payout ratio of 57%, indicating the company's ability to sustain dividend payments, appealing to investors seeking stable income.
- Dividend King Status: Both Colgate-Palmolive and American States Water are classified as
See More
- Market Volatility Impact: The U.S. stock market experienced significant volatility following the onset of the Iran war, with the S&P 500 index recovering 4.1% by April 17, yet higher energy prices may suppress consumer spending, potentially affecting overall market performance.
- High Dividend Yields: Colgate-Palmolive and American States Water achieved year-to-date returns of 9.3% and 5.5%, respectively, demonstrating the stability and appeal of these high-dividend stocks amid market turmoil.
- Colgate-Palmolive's Growth: The company anticipates a 1.4% sales increase for 2025 and generated $3.6 billion in free cash flow over the past year, ensuring the security of its dividends, with a recent 1.9% increase in quarterly payouts announced for May.
- American States Water's Stability: This utility company reported a 10.9% growth in adjusted diluted earnings per share to $3.37 for 2025, has paid dividends since 1931, and recently raised its dividend by 8.3% to $0.504 per share, reflecting strong financial health and commitment to shareholder returns.
See More
- Cybersecurity Investment Opportunity: Berenberg initiates coverage on Palo Alto Networks with a buy rating, highlighting its status as a 'best-in-class' player in cybersecurity, combining multiple growth engines and strong product breadth, which is expected to attract more investor interest in its sustained growth potential.
- Optimistic Tesla Outlook: Bank of America reiterates Tesla as a buy, anticipating that the upcoming Q1 earnings report will focus on its robotaxi deployments aimed at disrupting the rideshare market and capturing a portion of the $1 trillion market opportunity, showcasing its strategic advantage amid increasing competition.
- Packaging Industry Growth Potential: Raymond James upgrades Ball Corp to outperform, citing the company's strong performance in cost pass-throughs and structural support for the beverage sector, predicting it will achieve outsized growth compared to its packaging peers.
- Biopharma Market Prospects: Canaccord initiates AbbVie with a buy rating and a price target of $262, emphasizing its position as a 'core holding' and showcasing its strong growth potential and market appeal in the biopharmaceutical sector.
See More
- Dividend Increase: Procter & Gamble raised its quarterly dividend from $1.0568 to $1.0885 per share, resulting in an annual payout of $4.354 and a forward yield of 3%, reflecting the company's ongoing commitment to shareholder returns.
- Dividend King Status: This increase positions P&G among only five companies that have raised dividends for over 70 consecutive years, further solidifying its status as a Dividend King and attracting income-focused investors.
- Market Competitiveness: As the largest household and personal products company globally, P&G demonstrates resilience with an operating margin exceeding 20%, despite facing consumer spending challenges, showcasing its ability to maintain stability during economic fluctuations.
- Investment Opportunity: The recent stock sell-off has pushed P&G's dividend yield to a five-year high, with a price-to-earnings ratio of 21.4 and a forward P/E of 20.8, presenting an attractive buying opportunity for value investors looking to anchor their passive income portfolios.
See More
- Dividend Increase: Procter & Gamble raised its quarterly dividend from $1.0568 to $1.0885 per share, resulting in an annual payout of $4.354 and a forward yield of 3%, demonstrating the company's resilience amid economic slowdowns.
- Industry Position: As the largest household and personal products company globally, P&G ranks third in market capitalization among U.S. consumer staples, trailing only Walmart and Costco, highlighting its strong competitive edge in the market.
- Financial Health: With earnings per share at $6.75 and free cash flow at $6.09, P&G maintains a solid dividend payout ratio of 61.9%, indicating robust financial health while sustaining dividend growth.
- Market Adaptability: Despite consumer spending challenges, P&G effectively offsets weak performance in North America by leveraging a diversified product portfolio and geographic flexibility, ensuring continued growth in the global market.
See More
- Earnings Call Announcement: Colgate-Palmolive will host its Q1 2026 earnings conference call on May 1, 2026, at 8:30 a.m. ET, featuring insights from Chairman and CEO Noel Wallace and other executives, providing a detailed analysis of the company's financial performance.
- Investor Access: Investors can access the earnings press release, prepared materials, and the live audio webcast on Colgate's website, ensuring that all stakeholders stay informed about the latest financial updates and corporate developments.
- Recorded Playback Availability: For those unable to attend the live session, Colgate will offer a recorded version of the conference call, enhancing information accessibility and transparency for investors seeking to catch up on key discussions.
- Company Mission and Vision: Colgate is committed to promoting sustainability and community well-being through its innovative products in oral care, personal care, home care, and pet nutrition, highlighting its leadership position in the global market.
See More











